FDA Watch: EU’s New IVD Regulations Could Drive More Firms to Seek FDA Approval
Although the timelines have been extended several times, IVDR complexity has created a concerning bottleneck in the approval process
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Although the timelines have been extended several times, IVDR complexity has created a concerning bottleneck in the approval process
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
A laboratory safety expert shares the most common CLIA citations from recent lab inspections, and how your lab can avoid similar problems.
The choice of venue was likely inspired by the longstanding anti-regulatory stance of the state's federal judges.
Experts explain what the phase-in process will look like—and how labs can get ahead of the game.
Even the best labs can incur CLIA deficiencies when unprepared; this checklist can help your lab avoid some of the most common
Areas to address when preparing for your next CLIA inspection, based on recent data on top CLIA deficiencies
The new rule, slated to go into effect September 4, will ban noncompete agreements for most workers, including those in the lab industry
How labs form an indispensable part of the CMS National Quality Strategy, helping to drive healthcare improvements and scientific growth.
Genetic testing related fraud was a theme in recent enforcement actions involving medical laboratories and lab testing
Quality expert Sten Westgard discusses the latest CLIA update: “It’s time to have performance goals built in this century”